Home
Patients
Professionals
Trials
News
About

Neurology Image Library

Search

The Internet Stroke Center

Home » Blog » News » CYP2C19 reduces clopidogrelefficacy, ACS patient outcome

Post navigation

← Previous Next →

CYP2C19 reduces clopidogrelefficacy, ACS patient outcome

Posted on December 24, 2008 by Importer

http://www.medwire-news.md/news/article.aspx?k=62&id=79800

This entry was posted in News by Importer. Bookmark the permalink.

Comments are closed.

Patients & Families

Warning Signs
Reducing Your Risk
Information for Caregivers
Find a Trial

Professionals

Assessment Scales
Stroke Syndromes
Events & Conferences
Guidelines & Consensus Statements

Education

What is a Stroke?
Stroke Diagnosis
Anatomy of the Brain
Imaging Tests

We comply with the "Health on the Net" (HON) code of standards for trustworthy health information: verify here.

This project is supported in part by the NIH Specialized Programs of Translational Research in Acute Stroke (SPOTRIAS) Network, and NINDS grant 3P50NS055977 to Washington University in St. Louis School of Medicine and UT Southwestern Medical Center.

Copyright © 1997-2019 - The Internet Stroke Center. All rights reserved. The information contained in this web site is not a substitute for medical advice or treatment. Consultation with your doctor or health care professional is recommended.